Paul Lucas

Director at Ontario Genomics Institute (Private Equity)

Paul Lucas

Paul Lucas

Director at Ontario Genomics Institute (Private Equity)

Overview
Career Highlights

GlaxoSmithKline, Inc.

RelSci Relationships

284

Number of Boards

11

Birthday

1950

Age

68

Relationships
RelSci Relationships are individuals Paul Lucas likely has professional access to. A relationship does not necessarily indicate a personal connection.

Director & Co-Founder at Select Therapeutics, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at RNA Diagnostics, Inc.

Relationship likelihood: Strong

Chief Financial Officer at RNA Diagnostics, Inc.

Relationship likelihood: Strong

Founder at Abcann Medicinals, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Director at ABcann Global Corp.

Relationship likelihood: Strong

Former Executive Vice President at EMD Serono, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Director at EcoSynthetix, Inc.

Relationship likelihood: Strong

Honorary Professor at University of Western Ontario

Relationship likelihood: Strong

Treasurer at American Society for Microbiology

Relationship likelihood: Strong

Former Research Director Emeritus, Samuel Lunenfeld Research Institute at The Mount Sinai Hospital

Relationship likelihood: Strong

Paths to Paul Lucas
Potential Connections via
Relationship Science
You
Paul Lucas
Director at Ontario Genomics Institute (Private Equity)
Education

Queen's University at Kingston (commonly shortened to Queen's University or Queen's) is a public research university located in Kingston, Ontario, Canada. Founded on 16 October 1841, the university predated the founding of Canada by 26 years. Queen's holds more than 1,400 hectares (3,500 acres) of land throughout Ontario and owns Herstmonceux Castle in East Sussex, England. Queen's is organized into ten undergraduate, graduate and professional faculties and schools. The Church of Scotland established Queen's College in 1841 with a royal charter from Queen Victoria. The first classes, intended to prepare students for the ministry, were held 7 March 1842 with 13 students and two professors. Queen's was the first university west of the maritime provinces to admit women, and to form a student government. In 1883, a women's college for medical education affiliated with Queen's University. In 1888, Queen's University began offering extension courses, becoming the first Canadian university to do so. In 1912, Queen's secularized and changed to its present legal name.

Career History
Director
2009 - Current

Ontario Genomics Institute focuses on using world-class research to create strategic genomics resources and to accelerate Ontario's development of a globally-competitive life sciences sector. They strategically cultivate, fund and manage large-scale genomics projects and the genomics resources they create, as well as technology development and technology service platform provision associated with these projects. OGI aims to provide early-stage funding as companies (on their own or with academic collaborators) move towards commercial applications and to speed up transfer of products from lab to marketplace. The fund invests up to $100K per project. They tend to invest in the following sectors: Biofuels, Diagnostics, therapeutics, Crop or livestock trait improvements, Environmental management (related to water, mining, energy, other), Forestry, Laboratory and medical devices, Food, Informatics including databases, software, other tools.

President & Chief Executive Officer
1986 - 2012

GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada.

Professional
Prior

Eli Lilly Canada, Inc., a subsidiary of Eli Lilly & Co., is a Canadian company located in Scarborough, ON, focused on pharmaceutical preparations.

Boards & Committees
Chairman of the Board
2017 - Current

ABcann Global Corp. produces marijuana for medical purposes. The company focuses on curing diseases through medical cannabis. Its products include Si:med, Nc:med, Wp:med, Ic:med, Op:med, Sn:med and Dc:med. ABcann Global was founded by Ken Clement in 2007 and is headquartered in Napanee, Canada.

Chairman of the Board
2015 - Current

EcoSynthetix, Inc. engages in the commercializing a range of bio-based polymer and monomer products. The firm's products include DuraBind and EcoSphere, which are used to manufacture wood composites, paper, and packaging. The company was founded by John van Leeuwen and Steven Bloembergen in 1996 and is headquartered in Burlington, Canada.

Director
1998 - Current

Select Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is focused on the development of cell based therapeutics production. The company was founded by Clifford A. Lingwood in January 1997 and is headquartered in Brookline, MA.

Chairman, Board of Directors
Prior - 2017
Public Holdings
Restricted data only for RelSci Professional users.